Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.

Thomas Graier; Regina Fink-Puches; Stephanie Porkert; Roland Lang; Sophie Pöchlauer; Gudrun Ratzinger; Adrian Tanew; Sylvia Selhofer; Paul-Gunther Sator; Angelika Hofer; Alexandra Gruber-Wackernagel; Franz J Legat; Pablo Augusto Vieyra-Garcia; Franz Quehenberger; Peter Wolf

doi:10.3389/fmed.2020.00330

Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.

Thomas Graier
, Regina Fink-Puches
, Stephanie Porkert
, Roland Lang (Co-author)
, Sophie Pöchlauer
, Gudrun Ratzinger
, Adrian Tanew
, Sylvia Selhofer
, Paul-Gunther Sator
, Angelika Hofer
, Alexandra Gruber-Wackernagel
, Franz J Legat
, Pablo Augusto Vieyra-Garcia
, Franz Quehenberger
, Peter Wolf

Department of Dermatology and Allergology

Research output: Contribution to journal › Original Article › peer-review

15 Citations (Web of Science)

Original language	English
Pages (from-to)	330
Journal	FRONTIERS IN MEDICINE
Volume	7
DOIs	https://doi.org/10.3389/fmed.2020.00330
Publication status	Published - 2020

Keywords

T-CELL LYMPHOMA
CLINICAL-TRIAL
HOSPITAL ANXIETY
PHASE-II
BEXAROTENE
SKIN
THERAPY
ASSOCIATION
ULTRAVIOLET
PSORIASIS

Access to Document

10.3389/fmed.2020.00330

Cite this

Graier, T., Fink-Puches, R., Porkert, S., Lang, R., Pöchlauer, S., Ratzinger, G., Tanew, A., Selhofer, S., Sator, P.-G., Hofer, A., Gruber-Wackernagel, A., Legat, F. J., Vieyra-Garcia, P. A., Quehenberger, F., & Wolf, P. (2020). Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it. FRONTIERS IN MEDICINE, 7, 330. https://doi.org/10.3389/fmed.2020.00330

@article{c5e82aebd5254841ba2894b7dfb56020,

title = "Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.",

keywords = "T-CELL LYMPHOMA, CLINICAL-TRIAL, HOSPITAL ANXIETY, PHASE-II, BEXAROTENE, SKIN, THERAPY, ASSOCIATION, ULTRAVIOLET, PSORIASIS",

author = "Thomas Graier and Regina Fink-Puches and Stephanie Porkert and Roland Lang and Sophie P{\"o}chlauer and Gudrun Ratzinger and Adrian Tanew and Sylvia Selhofer and Paul-Gunther Sator and Angelika Hofer and Alexandra Gruber-Wackernagel and Legat, \{Franz J\} and Vieyra-Garcia, \{Pablo Augusto\} and Franz Quehenberger and Peter Wolf",

note = "Lang: Paracelsus Med Univ, Dept Dermatol \& Allergol, Salzburg, Austria",

year = "2020",

doi = "10.3389/fmed.2020.00330",

language = "English",

volume = "7",

pages = "330",

journal = "FRONTIERS IN MEDICINE",

issn = "2296-858X",

publisher = "Frontiers Media Sa",

}

Graier, T, Fink-Puches, R, Porkert, S, Lang, R, Pöchlauer, S, Ratzinger, G, Tanew, A, Selhofer, S, Sator, P-G, Hofer, A, Gruber-Wackernagel, A, Legat, FJ, Vieyra-Garcia, PA, Quehenberger, F & Wolf, P 2020, 'Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.', FRONTIERS IN MEDICINE, vol. 7, pp. 330. https://doi.org/10.3389/fmed.2020.00330

TY - JOUR

T1 - Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it.

AU - Graier, Thomas

AU - Fink-Puches, Regina

AU - Porkert, Stephanie

AU - Lang, Roland

AU - Pöchlauer, Sophie

AU - Ratzinger, Gudrun

AU - Tanew, Adrian

AU - Selhofer, Sylvia

AU - Sator, Paul-Gunther

AU - Hofer, Angelika

AU - Gruber-Wackernagel, Alexandra

AU - Legat, Franz J

AU - Vieyra-Garcia, Pablo Augusto

AU - Quehenberger, Franz

AU - Wolf, Peter

N1 - Lang: Paracelsus Med Univ, Dept Dermatol & Allergol, Salzburg, Austria

PY - 2020

Y1 - 2020

KW - T-CELL LYMPHOMA

KW - CLINICAL-TRIAL

KW - HOSPITAL ANXIETY

KW - PHASE-II

KW - BEXAROTENE

KW - SKIN

KW - THERAPY

KW - ASSOCIATION

KW - ULTRAVIOLET

KW - PSORIASIS

U2 - 10.3389/fmed.2020.00330

DO - 10.3389/fmed.2020.00330

M3 - Original Article

C2 - 32850876

SN - 2296-858X

VL - 7

SP - 330

JO - FRONTIERS IN MEDICINE

JF - FRONTIERS IN MEDICINE

ER -